Short Interest in Vimian Group AB (publ) (OTCMKTS:VIMGF) Drops By 51.6%

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the recipient of a significant decline in short interest in September. As of September 30th, there was short interest totalling 282,000 shares, a decline of 51.6% from the September 15th total of 582,700 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Vimian Group AB (publ) Stock Performance

VIMGF stock remained flat at C$4.12 during trading on Friday. The business’s fifty day simple moving average is C$3.74 and its 200-day simple moving average is C$2.99. Vimian Group AB has a fifty-two week low of C$2.68 and a fifty-two week high of C$4.12.

Vimian Group AB (publ) Company Profile

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.